Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are five patents protecting…
The post New patent for Chiesi drug FERRIPROX appeared first on Dr…
This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Portug…
Which pharmaceutical drugs have the most drug patents in Portugal? Read Post »
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…
The post New patent for Boehringer Ingelheim drug TRADJENTA appe…
New patent for Boehringer Ingelheim drug TRADJENTA Read Post »
Annual Drug Patent Expirations for BALCOLTRA Balcoltra is a drug marketed by Avion Pharms and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…
The post New patent expiration for Avion Pharms drug BALCOLTRA appea…
New patent expiration for Avion Pharms drug BALCOLTRA Read Post »
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWat…
Annual Drug Patent Expirations for CHILDREN%27S+ASTEPRO+ALLERGY For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New p…
New patent for Bayer Hlthcare drug CHILDREN’S ASTEPRO ALLERGY Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appeared…
New patent for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for SUTENT Sutent is a drug marketed by Cppi Cv and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Cppi Cv drug SUTENT appeared first on DrugPatentWa…
Annual Drug Patent Expirations for ASTEPRO+ALLERGY Astepro Allergy is a drug marketed by Bayer Hlthcare and is included in one NDA. The generic ingredient in ASTEPRO ALLERGY is azelastine hydrochloride.…
The post New patent for Bayer Hlthcare drug ASTE…
New patent for Bayer Hlthcare drug ASTEPRO ALLERGY Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Get new actionable insights and updates from BiotechBlog
